5 Results

People

  1. Moskowitz
    Moskowitz
  2. Baik
    Baik
  3. Bajorin
    Bajorin
  4. Belum
    Belum
  5. Benhuri
    Benhuri
  6. Betof Warner
    Betof Warner
  7. Busam
    Busam
  8. Dogan
    Dogan
  9. Gao
    Gao
  10. Hellmann
    Hellmann

Groups

  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (4)
  3. Center for Hematologic Malignancies (3)
  4. Solid Tumor Oncology Division (3)
  5. Department of Pathology and Laboratory Medicine (2)
  6. Genitourinary Oncology Service (2)
  7. Lymphoma (2)
  8. Melanoma Disease Management Team (2)
  9. Melanoma and Immunotherapeutics Service (2)
  10. Dermatology Service (1)
  1. "programmed death-1"
Formats
  1. Journal Article (4)
  2. Review (1)
Groups
  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (4)
  3. Center for Hematologic Malignancies (3)
  4. Solid Tumor Oncology Division (3)
  5. Department of Pathology and Laboratory Medicine (2)
  6. Genitourinary Oncology Service (2)

More Groups

People
  1. Alison Moskowitz (2)
  2. Ahmet Dogan (1)
  3. Alexander Lesokhin (1)
  4. Alexander Shoushtari (1)
  5. Allison Betof Warner (1)
  6. Allison Sigler (1)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2016 (2)
Publications
  1. European Journal of Cancer (2)
  2. Current Opinion in Oncology (1)
  3. Cytometry Part B—Clinical Cytometry (1)
  4. Lancet (1)
Publishers
  1. Elsevier Inc. (2)
  2. Elsevier Science, Inc. (1)
  3. Lippincott Williams & Wilkins (1)
  4. Wiley Blackwell (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • What is the best salvage therapy for Hodgkin lymphoma?
    Review

    Luttwak, E.; Moskowitz, A. J.
    Current Opinion in Oncology (2024)

    Fulltext@MSK | Save
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
    Journal Article

    Lewis, N. E.; Gao, Q.; Petrova-Drus, K.; Pulitzer, M.; Sigler, A.; Baik, J.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2022)

    Fulltext@MSK | Save
  • Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial
    Journal Article

    Rosenberg, J. E.; Hoffman-Censits, J.; Powles, T.; van der Heijden, M. S.; Balar, A. V.; Necchi, A.; Dawson, N.; O'Donnell, P. H.; Balmanoukian, A.; Loriot, Y.; more...
    Lancet (2016)

    Fulltext@MSK | Save
  • Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
    Journal Article

    Belum, V. R.; Benhuri, B.; Postow, M. A.; Hellmann, M. D.; Lesokhin, A. M.; Segal, N. H.; Motzer, R. J.; Wu, S.; Busam, K. J.; Wolchok, J. D.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save